Atrial fibrillation in cardiac resynchronization therapy

Mark K Elliott1,2, Vishal S Mehta1,2, Dejana Martic2

  • 1School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.

Heart Rhythm O2
|January 6, 2022
PubMed

Insights

Atrial fibrillation (AF) complicates cardiac resynchronization therapy (CRT) response in heart failure patients. This review explores AF management strategies alongside CRT for improved outcomes.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Background:

  • Up to 40% of patients receiving cardiac resynchronization therapy (CRT) have atrial fibrillation (AF), yet they were excluded from major clinical trials.
  • AF can reduce CRT effectiveness by decreasing biventricular pacing and atrioventricular synchrony.
  • Cardiac remodeling from CRT may also impact AF progression.

Purpose of the Study:

  • To review the complex interactions between AF, heart failure, and CRT.
  • To discuss current evidence for managing AF in patients undergoing CRT.

Main Methods:

  • Literature review of studies on AF, heart failure, and CRT.
  • Analysis of management strategies including rate and rhythm control, and AF catheter ablation.
  • Evaluation of evidence from observational and randomized trials.

Main Results:

  • AF significantly attenuates CRT response due to reduced pacing and loss of synchrony.
  • CRT may influence the progression of AF through cardiac remodeling.
  • Management options for AF in CRT patients include rate control, rhythm control, and catheter ablation.

Conclusions:

  • Managing AF in CRT patients is complex due to limited direct evidence.
  • Current treatment strategies for AF in this cohort are largely based on observational data or extrapolated from broader heart failure populations.
  • Further research is needed to optimize AF management in patients receiving CRT.

Related Concept Videos

Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.5K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
195
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
50
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
145
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
85
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
110